Paper31981925
R-Roscovitine Improves Motoneuron Function in Mouse Models for Spinal Muscular Atrophy.
Tejero R and 14 others. iScience, 2020. Cited by 20 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. R-Roscovitine Improves Motoneuron Function in Mouse Models for Spinal Muscular Atrophy. Papers, record 31981925. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/31981925
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References65
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 18,216,203 | Exercise-induced activation of NMDA receptor promotes motor unit development and survival in a type 2 spinal muscular atrophy model mouse. | J Neurosci | 2008 | https://conductscience.org/library/papers/18216203 | PubMed |
| 2 | 29,091,557 | Single-Dose Gene-Replacement Therapy for Spinal Muscular Atrophy. | N Engl J Med | 2017 | https://conductscience.org/library/papers/29091557 | PubMed |
| 3 | 28,504,671 | Reduced sensory synaptic excitation impairs motor neuron function via Kv2.1 in spinal muscular atrophy. | Nat Neurosci | 2017 | https://conductscience.org/library/papers/28504671 | PubMed |
| 4 | 17,923,533 | Defective Ca2+ channel clustering in axon terminals disturbs excitability in motoneurons in spinal muscular atrophy. | J Cell Biol | 2007 | https://conductscience.org/library/papers/17923533 | PubMed |
| 5 | 24,011,867 | Targeting cyclin-dependent kinases in anti-neoplastic therapy. | Curr Opin Cell Biol | 2013 | https://conductscience.org/library/papers/24011867 | PubMed |
| 6 | 9,845,364 | A novel function for SMN, the spinal muscular atrophy disease gene product, in pre-mRNA splicing. | Cell | 1998 | https://conductscience.org/library/papers/9845364 | PubMed |
| 7 | 26,987,072 | Modulating Innate and Adaptive Immunity by (R)-Roscovitine: Potential Therapeutic Opportunity in Cystic Fibrosis. | J Innate Immun | 2016 | https://conductscience.org/library/papers/26987072 | PubMed |
| 8 | 17,970,192 | Effect of L-type calcium channel blockers on activity of newly formed synapses in mice. | Bull Exp Biol Med | 2007 | https://conductscience.org/library/papers/17970192 | PubMed |
| 9 | 9,207,792 | Correlation between severity and SMN protein level in spinal muscular atrophy. | Nat Genet | 1997 | https://conductscience.org/library/papers/9207792 | PubMed |
| 10 | 14,623,865 | Smn, the spinal muscular atrophy-determining gene product, modulates axon growth and localization of beta-actin mRNA in growth cones of motoneurons. | J Cell Biol | 2003 | https://conductscience.org/library/papers/14623865 | PubMed |
| 11 | 8,994,064 | Novel modulatory effect of L-type calcium channels at newly formed neuromuscular junctions. | J Neurosci | 1997 | https://conductscience.org/library/papers/8994064 | PubMed |
| 12 | 22,805,911 | Calcium channel auxiliary α2δ and β subunits: trafficking and one step beyond. | Nat Rev Neurosci | 2012 | https://conductscience.org/library/papers/22805911 | PubMed |
| 13 | 18,485,868 | SMN deficiency causes tissue-specific perturbations in the repertoire of snRNAs and widespread defects in splicing. | Cell | 2008 | https://conductscience.org/library/papers/18485868 | PubMed |
| 14 | 15,657,360 | Metabolism and pharmacokinetics of the cyclin-dependent kinase inhibitor R-roscovitine in the mouse. | Mol Cancer Ther | 2005 | https://conductscience.org/library/papers/15657360 | PubMed |
| 15 | 19,158,308 | Impaired synaptic vesicle release and immaturity of neuromuscular junctions in spinal muscular atrophy mice. | J Neurosci | 2009 | https://conductscience.org/library/papers/19158308 | PubMed |
| 16 | 11,923,424 | Cdk5/p35 regulates neurotransmitter release through phosphorylation and downregulation of P/Q-type voltage-dependent calcium channel activity. | J Neurosci | 2002 | https://conductscience.org/library/papers/11923424 | PubMed |
| 17 | 23,063,130 | SMN is required for sensory-motor circuit function in Drosophila. | Cell | 2012 | https://conductscience.org/library/papers/23063130 | PubMed |
| 18 | 28,173,138 | Synaptotagmin-2, and -1, linked to neurotransmission impairment and vulnerability in Spinal Muscular Atrophy. | Hum Mol Genet | 2016 | https://conductscience.org/library/papers/28173138 | PubMed |
| 19 | 23,785,168 | Evaluation of a novel calcium channel agonist for therapeutic potential in Lambert-Eaton myasthenic syndrome. | J Neurosci | 2013 | https://conductscience.org/library/papers/23785168 | PubMed |
| 20 | 25,246,652 | Subcellular transcriptome alterations in a cell culture model of spinal muscular atrophy point to widespread defects in axonal growth and presynaptic differentiation. | RNA | 2014 | https://conductscience.org/library/papers/25246652 | PubMed |
Cited by18
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 20 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41,872,133 | The amino acid transporter LAT1 coordinates proper motor function at the perinatal stage. | Cell Death Dis | 2026 | https://conductscience.org/library/papers/41872133 | PubMed |
| 41,028,013 | Munc13-1 restoration mitigates presynaptic pathology in spinal muscular atrophy. | Nat Commun | 2025 | https://conductscience.org/library/papers/41028013 | PubMed |
| 40,906,176 | Managing Spinal Muscular Atrophy: A Look at the Biology and Treatment Strategies. | Biology (Basel) | 2025 | https://conductscience.org/library/papers/40906176 | PubMed |
| 40,038,284 | Functional optic tract rewiring via subtype- and target-specific axonal regeneration and presynaptic activity enhancement. | Nat Commun | 2025 | https://conductscience.org/library/papers/40038284 | PubMed |
| 39,666,039 | Cytoskeleton dysfunction of motor neuron in spinal muscular atrophy. | J Neurol | 2024 | https://conductscience.org/library/papers/39666039 | PubMed |
| 39,596,381 | Roscovitine, a CDK Inhibitor, Reduced Neuronal Toxicity of mHTT by Targeting HTT Phosphorylation at S1181 and S1201 In Vitro. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39596381 | PubMed |
| 38,269,114 | Impaired communication at the neuromotor axis during Degenerative Cervical Myelopathy. | Front Cell Neurosci | 2023 | https://conductscience.org/library/papers/38269114 | PubMed |
| 38,249,130 | The SMA Modifier Plastin 3 Targets Cell Membrane-Associated Proteins in Motoneurons. | Neurosci Insights | 2024 | https://conductscience.org/library/papers/38249130 | PubMed |
| 37,976,261 | Mitigating aberrant Cdk5 activation alleviates mitochondrial defects and motor neuron disease symptoms in spinal muscular atrophy. | Proc Natl Acad Sci U S A | 2023 | https://conductscience.org/library/papers/37976261 | PubMed |
| 37,108,811 | Nifedipine Ameliorates Cellular Differentiation Defects of Smn-Deficient Motor Neurons and Enhances Neuromuscular Transmission in SMA Mice. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37108811 | PubMed |
| 36,607,273 | Plastin 3 rescues cell surface translocation and activation of TrkB in spinal muscular atrophy. | J Cell Biol | 2023 | https://conductscience.org/library/papers/36607273 | PubMed |
| 35,966,199 | The role of Cdk5 in neurological disorders. | Front Cell Neurosci | 2022 | https://conductscience.org/library/papers/35966199 | PubMed |
| 34,983,696 | Therapy development for spinal muscular atrophy: perspectives for muscular dystrophies and neurodegenerative disorders. | Neurol Res Pract | 2022 | https://conductscience.org/library/papers/34983696 | PubMed |
| 34,337,562 | Spinal muscular atrophy: From approved therapies to future therapeutic targets for personalized medicine. | Cell Rep Med | 2021 | https://conductscience.org/library/papers/34337562 | PubMed |
| 33,693,569 | Calcium is reduced in presynaptic mitochondria of motor nerve terminals during neurotransmission in SMA mice. | Hum Mol Genet | 2021 | https://conductscience.org/library/papers/33693569 | PubMed |
| 33,562,482 | In Search of a Cure: The Development of Therapeutics to Alter the Progression of Spinal Muscular Atrophy. | Brain Sci | 2021 | https://conductscience.org/library/papers/33562482 | PubMed |
| 33,281,605 | Drug Screening and Drug Repositioning as Promising Therapeutic Approaches for Spinal Muscular Atrophy Treatment. | Front Pharmacol | 2020 | https://conductscience.org/library/papers/33281605 | PubMed |
| 32,848,618 | The Mouse Levator Auris Longus Muscle: An Amenable Model System to Study the Role of Postsynaptic Proteins to the Maintenance and Regeneration of the Neuromuscular Synapse. | Front Cell Neurosci | 2020 | https://conductscience.org/library/papers/32848618 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CACNA1A | 773 | PubTator's text mining | https://conductscience.org/library/genes/773 | NCBI Gene |
| CACNA1B | 774 | PubTator's text mining | https://conductscience.org/library/genes/774 | NCBI Gene |
| SMN1 | 6,606 | PubTator's text mining | https://conductscience.org/library/genes/6606 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/31981925
GET https://conductscience.org/api/papers/v1/31981925/references?page=2